CEVA, Inc.: UBS cuts target price to $35 from $40
CEVA•UBS cut its target price for CEVA to $35 from $40.
Related News
Safe Pro Group awarded U.S. Army prime contract, teams with Anduril on Ghost-X drone
SPAI•
Siebert Financial flags S&P 500 concentration risk as NVIDIA selloff exposes index vulnerability
SPY•
GeneDx study finds 62% of patients with pathogenic or likely pathogenic findings have actionable results
WGS•
Turn Therapeutics presents GX-03 Phase 2a data for atopic dermatitis
TTRX•
Curtiss-Wright wins contracts worth over $140 million for U.S. Navy submarines
GD•